Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Founded over 30 years ago, G2 Intelligence is a premier information services provider catering to the dynamic needs of the medical laboratory industry. Our mission is to empower lab managers, professionals, and industry leaders to navigate legal requirements, optimize operational efficiency, enhance clinical quality, and drive profitability.
Monthly Reports
Lab Industry Advisor is a subscription-based, online briefing that keeps readers up to date on the latest legal, compliance, and business developments affecting the lab industry. Lab Industry Advisor offers analysis and insight from expert sources to help lab leaders meet their financial and business goals.
Clinical Diagnostics Insider, a spinoff of Lab Industry Advisor, is a subscription-based, online resource aimed at clinical lab scientists. It provides in-depth expert analysis of emerging diagnostics tests and disruptive technologies in the lab industry.
Webinars & Digital Events
Webinar presentations offer expert advice and education on critical topics for medical lab professionals, covering the legal, regulatory, compliance, and science and technology aspects of the industry throughout the year. Our 2024 calendar includes 11 webinars.
Lab Institute is a free virtual, two-day event including a variety of experts focused on one key theme in the medical lab industry. Including at least six presentations, our virtual events help lab leaders stay current on the latest requirements for labs and connect them with experts who offer solutions to the most pressing problems facing medical labs today. We plan to offer both a spring and fall Lab Institute in 2024.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
Quick Guide to Recent Changes We’ve Made to G2’s Reports
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
Compliance Tool: 8 Questions to Ask About Digital Pathology Business Arrangements
This checklist can help labs monitor their organization’s business arrangements that concern digital pathology to ensure compliance.
Digital Pathology Business Arrangements Bring Fraud and Kickback Worries
Healthcare attorneys explain three digital pathology models for laboratories to be aware of.
FDA Watch: New BD Collection System Uses Just Tiny Amounts of Blood
Whether the MiniDraw™ device dredges up memories of Theranos’ failed tech remains to be seen.
Dx Deals Roundup: Pact Aims to Improve Prostate Cancer Detection Among Hispanic Males
More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.
Recent FDA Approvals Show Growing Sophistication of At-Home Tests
Once confined to areas such as pregnancy testing, these assays can now be used to detect STIs and other health issues.
Special Report: How to Avoid Problematic Lab Business Arrangements
When structuring business arrangements, addressing six key risk areas can help laboratories avoid major compliance issues.
Expert Q&A: Trends and Challenges in Lab Billing and Coding
Ann Lambrix, vice president of RCM Solutions at Lighthouse Lab Services, discusses key developments in lab billing and coding.
February 2024 Labs in Court
Recent cases show labs should be wary of issues such as improper relationships, medical necessity, kickbacks, and potential telehealth fraud.
At-Home Answers in Infectious Disease
Demand for at-home sample collection and infectious disease testing is at an all-time high—and still growing.
Expert Q&A: Adapting to the Expanding Market of At-Home Testing
Medical director William G. Finn, MD, discusses key trends, challenges, and opportunities related to the expansion of at-home testing.